The FDA approved drug Provenge has been a welcome advance in treating advanced prostate cancer.? It works by training the body?s immune system to find and attack prostate cancer cells.
For the first time researchers at Georgia?s Health Sciences University are conducting clinical trials combining Provenge with two other cancer-fighting drugs to further improve life expectancy.? The two are CT-011 and cyclophosphamide.
Provenge has been found to extend life? by nearly 20% and the lead scientist Dr. Samir Khleif says the latest tests represent the latest attempt to eradicate the disease completely. Both of these drugs used alone have been shown to reverse immune suppression caused by cancer.? But they?ve never been combined before in treating prostate cancer.? Pre clinical trials in Dr. Khlieif?s lab found that the combination of Provenge with these two drugs led to a significant increase in survival and complete tumor regression in more than 50% of the mice.? Based on these results, the makers of Provenge?Dendreon Corporation?and Dr. Khleif are collaborating on this first in human trial.
?
?
Source: http://www.prostatecancersurvivorspeak.com/new-trials-for-advanced-prostate-cancer/
lake havasu halo 4 jewel san francisco earthquake san francisco earthquake terminator salvation terminator salvation
No comments:
Post a Comment